ライフサイエンスコーパス: fluorescein angiography

1 4, and vascular permeability was analyzed by fluorescein angiography.

2 al iris vessels, not distinct on intravenous fluorescein angiography.

3 were more distinct on OCTA than intravenous fluorescein angiography.

4 linical examination, fundus photography, and fluorescein angiography.

5 etinal capillary flow data in the absence of fluorescein angiography.

6 ptical coherence tomography (OCT) and fundus fluorescein angiography.

7 hy, wide-field color fundus photography, and fluorescein angiography.

8 a, with higher resolution than observed with fluorescein angiography.

9 inal blood flow velocities measured by video fluorescein angiography.

10 , optical coherence tomography (OCT), and/or fluorescein angiography.

11 teristics on optical coherence tomography or fluorescein angiography.

12 sions are visible on clinical examination or fluorescein angiography.

13 esions visible on ICGA but not detectable on fluorescein angiography.

14 s the late staining seen during conventional fluorescein angiography.

15 ain optical coherence tomography, and fundus fluorescein angiography.

16 RS) scale, optical coherence tomography, and fluorescein angiography.

17 l vessel leakage were found in the follow-up fluorescein angiography.

18 and delayed or absent choroidal perfusion on fluorescein angiography.

19 with the final diagnosis made using ICGA and fluorescein angiography.

20 that are easily identified using wide-field fluorescein angiography.

21 nd the area of vessel leakage evaluated with fluorescein angiography.

22 ities that were clearly visible with FAF and fluorescein angiography.

23 vascularization (CNV) model in monkeys using fluorescein angiography.

24 chemistry, Western blot analysis, and fundus fluorescein angiography.

25 analyzed by scotopic electroretinography and fluorescein angiography.

26 me an important adjunct to biomicroscopy and fluorescein angiography.

27 and the progression of CNV was evaluated by fluorescein angiography.

28 munohistochemistry, electroretinography, and fluorescein angiography.

29 ant postsurgical CME and is complementary to fluorescein angiography.

30 sual acuity testing, fundus photography, and fluorescein angiography.

31 rculation time (MCT) were evaluated by video fluorescein angiography.

32 e choroidal neovascularization at week 12 on fluorescein angiography.

33 or photos, optical coherence tomography, and fluorescein angiography.

34 with resolved macular edema, and leakage on fluorescein angiography.

35 al vasculature with lower risk and cost than fluorescein angiography.

36 Fluorescein angiography, a combination of 2 OCT protocol

37 abnormalities are typically evaluated using fluorescein angiography, a modality with known defects i

38 Fluorescein angiography after bevacizumab for ROP reveal

39 Widefield fluorescein angiography analysis of 95 eyes (53 patients

40 Laser-induced CNV was evaluated by fluorescein angiography and choroidal flat mounts.

41 CNV was examined by fluorescein angiography and choroidal flatmount.

42 Fundus fluorescein angiography and Doppler US were used to eval

43 Fluorescein angiography and fundus autofluorescence were

44 graded scar and GA on fundus photography and fluorescein angiography and graded SHRM on time-domain a

45 The lesions were evaluated by fluorescein angiography and histopathology.

46 aluation, which included fundus photography, fluorescein angiography and ICGA.

47 Visual acuity, color images, and fluorescein angiography and indocyanine green angiograph

48 Baseline fluorescein angiography and indocyanine green angiograph

49 tion in the left eye, which was confirmed by fluorescein angiography and indocyanine green angiograph

50 mice (aged 16 to 52 weeks) were subjected to fluorescein angiography and optical coherence tomography

51 al required that study eyes have evidence on fluorescein angiography and optical coherence tomography

52 Retinal fluorescein angiography and optical coherence tomography

53 without diabetic macular edema and underwent fluorescein angiography and SD-OCT for diabetic retinopa

54 r more at 6 months, the change in leakage on fluorescein angiography and the change in foveal thickne

55 zation and/or peripheral avascular retina on fluorescein angiography and were treated with laser.

56 of the retina, a layer poorly visualized by fluorescein angiography and, to a lesser extent, in the

57 tinal neovascularization was evaluated using fluorescein-angiography and counting preretinal vascular

58 traretinal cysts on SD OCT or dye leakage on fluorescein angiography) and responded to treatment with

59 Leakage was assessed by fluorescein angiography, and CNV lesion size was quantif

60 Ocular examination, visual field, fluorescein angiography, and electrophysiology testing w

61 cs, such as early onset, cuticular drusen on fluorescein angiography, and family history of AMD.

62 gnostic tests (optical coherence tomography, fluorescein angiography, and fundus photography) and the

63 gnosed with RAP based on fundus examination, fluorescein angiography, and indocyanine green angiograp

64 ocolor photography, fundus autofluorescence, fluorescein angiography, and indocyanine green angiograp

65 ocols, and included CFP, multicolor imaging, fluorescein angiography, and indocyanine green angiograp

66 color photographs, fundus autofluorescence, fluorescein angiography, and indocyanine-green angiograp

67 y, fundus photography, indocyanine green and fluorescein angiography, and magnetic resonance imaging)

68 domain OCT, autofluorescence imaging, fundus fluorescein angiography, and OCT angiography (OCTA) were

69 etails and images (color fundus photography, fluorescein angiography, and OCT) for all investigator-d

70 rrected visual acuity, fundus biomicroscopy, fluorescein angiography, and OCT.

71 inical examination, fundus autofluorescence, fluorescein angiography, and optical coherence tomograph

72 nical examination, color fundus photography, fluorescein angiography, and optical coherence tomograph

73 anibizumab, bevacizumab, fundus photographs, fluorescein angiography, and optical coherence tomograph

74 a-ocular pressure, results of fundoscopy and fluorescein angiography, and outcomes two months after t

75 isions on the need to perform or not perform fluorescein angiography, and regarding treatment or retr

76 tures, refractive error, fundus examination, fluorescein angiography, and SD OCT findings at onset of

77 , infrared imaging, fundus autofluorescence, fluorescein angiography, and spectral domain-optical coh

78 free photographs, near-infrared reflectance, fluorescein angiography, and spectral-domain optical coh

79 inical examination, fundus autofluorescence, fluorescein angiography, and spectral-domain optical coh

80 by (1) the presence of hyperfluorescence on fluorescein angiography; and (2) at least one other char

81 HP), optical coherence tomography (OCT), and fluorescein angiography are tools that may be used to de

82 r pigment (MP), OCT, blue light reflectance, fluorescein angiography, as well as fundus photography,

83 omes were evaluated among eyes with gradable fluorescein angiography at baseline (n = 973) and at 1 y

84 Live fundus imaging and fluorescein angiography at P17 were compared to immunofl

85 had multimodal imaging (fundus photography, fluorescein angiography, autofluorescence, and spectral-

86 Retinal perfusion status was evaluated by fluorescein angiography based on the presence or absence

87 a monthly basis with fundus photography and fluorescein angiography before and after each IAC inject

88 Fluorescein angiography can be an important tool in eval

89 This information in combination with ICG and fluorescein angiography can help to optimize direct lase

90 tudy, ERG responses were obtained along with fluorescein angiography, CBCs, and melphalan plasma conc

91 ection rate, or optical coherence tomography/fluorescein angiography changes).

92 ment of retinal detachment was assessed with fluorescein angiography, clinical examination, or both.

93 ocular coherence tomography (OCT), and with fluorescein angiography confirmation.

94 Fluorescein angiography confirmed the sea fan neovascula

95 Retinal fluorescein angiography demonstrated delayed perfusion a

96 Fluorescein angiography demonstrated peripheral retinal

97 Fluorescein angiography demonstrates arterial wall hyper

98 ificantly larger CNV with greater leakage on fluorescein angiography developed in mutant mice.

99 Fluorescein angiography disclosed early retinal hypofluo

100 Fluorescein angiography does not image the radial peripa

101 An 86-year old Caucasian woman undergoing fluorescein angiography due to suspected peripapillary n

102 Fluorescein angiography, especially with widefield capab

103 ers, including signs of ocular inflammation, fluorescein angiography evidence of retinal vasculitis o

104 examination plus simulated 30- or 60-degree fluorescein angiography (FA) (obtained by physically nar

105 l study, 15 eyes with DR were evaluated with fluorescein angiography (FA) and color fundus photograph

106 All images from subjects with same-day UWF fluorescein angiography (FA) and color imaging were eval

107 Concurrent fluorescein angiography (FA) and indocyanine green angio

108 autofluorescence (FAF), dynamic simultaneous fluorescein angiography (FA) and indocyanine green angio

109 Color, fluorescein angiography (FA) and OCT images acquired at

110 V detection compared to the gold standard of fluorescein angiography (FA) and OCT was determined for

111 clinical examination, as well as findings on fluorescein angiography (FA) and OCT.

112 this study using two images from each fundus fluorescein angiography (FA) and pvOCT, the measured ave

113 ting, refraction, dilated fundus examination fluorescein angiography (FA) and SD-OCT (spectral Domain

114 Fluorescein angiography (FA) and SS-OCTA imaging (PLEX E

115 Patients were imaged longitudinally with fluorescein angiography (FA) and swept-source (SS) OCT a

116 , and optical coherence tomography (OCT) and fluorescein angiography (FA) examinations in 12 months.

117 Our aim was to describe the fluorescein angiography (FA) findings in patients who re

118 CTA) was compared with ultrawide-field (UWF) fluorescein angiography (FA) for evaluating neovasculari

119 We compare images from PV-OCT and fluorescein angiography (FA) for normal individuals and

120 e authors also compared their method against fluorescein angiography (FA) for one subject.

121 of patients who underwent same-day OCTA and fluorescein angiography (FA) for suspected CNV was evalu

122 Ultra-widefield fluorescein angiography (FA) images and spectral-domain

123 SD-OCT and fluorescein angiography (FA) images of 93 eyes of 93 pat

124 Baseline fluorescein angiography (FA) images of all CATT study ey

125 Color fundus photography and fluorescein angiography (FA) images were used to create

126 evaluated digital color fundus photographs, fluorescein angiography (FA) images, and optical coheren

127 ging was compared with ultra-widefield (UWF) fluorescein angiography (FA) imaging to better understan

128 Fluorescein angiography (FA) is a procedure used to imag

129 when analyzed by age, race, fluence setting, fluorescein angiography (FA) leakage type, corticosteroi

130 Detecting CNV using fluorescein angiography (FA) may be challenging owing to

131 Fluorescein angiography (FA) may become necessary to eva

132 Fluorescein angiography (FA) results assessed by masked,

133 cystoid macular edema (CME), and the highest fluorescein angiography (FA) score during the course of

134 All image frames of a fluorescein angiography (FA) sequence are first aligned

135 Fluorescein angiography (FA) showed nonspecific retinal

136 Fluorescein angiography (FA) showed very severe leakage

137 rescence area and intensity over time during fluorescein angiography (FA) using a continuous scale an

138 Digital fundus photographs and fluorescein angiography (FA) using the RetCam (Clarity M

139 Fluorescein angiography (FA) was acquired at baseline, 3

140 Ultra-widefield fluorescein angiography (FA) was also performed when cli

141 Fluorescein angiography (FA) was performed at 14 days, a

142 Fluorescein angiography (FA) was performed at day 5, 7,

143 Fluorescein angiography (FA) was performed in 113 eyes,

144 c retinopathy (PDR) on ultra-widefield (UWF) fluorescein angiography (FA) were identified and compare

145 Digital retinal imaging and fluorescein angiography (FA) were performed at an averag

146 ry, vein or uncertain) assessed by IR and/or fluorescein angiography (FA) were referenced as ground t

147 mic examination, OCT angiography (OCTA), and fluorescein angiography (FA) with widefield imaging.

148 atients underwent SS OCT angiography (OCTA), fluorescein angiography (FA), and indocyanine green angi

149 pectral-domain optical coherence tomography, fluorescein angiography (FA), and indocyanine green angi

150 examination including structural OCT, OCT-A, fluorescein angiography (FA), and indocyanine green angi

151 Fundus photography, OCT, fluorescein angiography (FA), and OCT angiography were p

152 w-up morphology in color fundus photographs, fluorescein angiography (FA), and optical coherence tomo

153 weeks and included color fundus photography, fluorescein angiography (FA), and optical coherence tomo

154 ollow-up morphology on digital color images, fluorescein angiography (FA), and optical coherence tomo

155 visual acuity (BCVA), fundus biomicroscopy, fluorescein angiography (FA), and SDOCT.

156 a comprehensive ophthalmologic examination, fluorescein angiography (FA), and spectral-domain optica

157 We performed following examinations: fluorescein angiography (FA), B-scan ultrasound, spectra

158 ged with optical coherence tomography (OCT), fluorescein angiography (FA), blue fundus autofluorescen

159 Optical coherence tomography (OCT), fluorescein angiography (FA), color fundus photography (

160 CNV development were evaluated at day 14 by fluorescein angiography (FA), confocal volumetric analys

161 ding visual acuity (VA), fundus photography, fluorescein angiography (FA), fundus autofluorescence (F

162 photographs, fundus autofluorescence (FAF), fluorescein angiography (FA), indocyanine green angiogra

163 Fundus photography, fluorescein angiography (FA), indocyanine green angiogra

164 Imaging features obtained using fluorescein angiography (FA), indocyanine green angiogra

165 ence of fluid on OCT, presence of leakage on fluorescein angiography (FA), mean change in lesion size

166 uipment, including color fundus photography, fluorescein angiography (FA), OCT, and PAM, was used to

167 raphy, fundus photography, autofluorescence, fluorescein angiography (FA), optical coherence tomograp

168 photography, fundus autofluorescence (FAF), fluorescein angiography (FA), spectral-domain optical co

169 A), Amsler grid testing, fundus photography, fluorescein angiography (FA), spectral-domain optical co

170 ed by optical coherence tomography (OCT) and fluorescein angiography (FA).

171 art, optical coherence tomography (OCT), and fluorescein angiography (FA).

172 d with commercially available 70-kHz OCT and fluorescein angiography (FA).

173 d sizes and locations that were confirmed by fluorescein angiography (FA).

174 art, optical coherence tomography (OCT), and fluorescein angiography (FA).

175 fundus examination, fundus photography, and fluorescein angiography (FA).

176 opy, optical coherence tomography (OCT), and fluorescein angiography (FA).

177 ence tomography (SD-OCT) and late leakage on fluorescein angiography (FA).

178 O and CRAO were established as affirmed with fluorescein angiography (FA).

179 herence tomography angiography (SS-OCTA) and fluorescein angiography (FA).

180 l records of patients with nAMD confirmed on fluorescein angiography (FA).

181 giography, fundus autofluorescence (FAF) and fluorescein-angiography (FA).

182 ging modalities (ultrasound of the arteries; fluorescein angiography, FA; MRI; and positron emission

183 Fundus fluorescein angiography (FAG) revealed central hypofluor

184 Traditionally, fundus fluorescein angiography (FFA) has been considered the re

185 entation of the FAZ using images from fundus fluorescein angiography (FFA) was applied to 26 transit-

186 studied using fundus imaging, SS-OCT, fundus fluorescein angiography (FFA), and indocyanine green ang

187 undus autofluorescence (FAF) imaging, fundus fluorescein angiography (FFA), and optical coherence tom

188 raphy (ERG), fundus photography (FP), fundus fluorescein angiography (FFA), and optical coherence tom

189 The findings were compared with fundus fluorescein angiography (FFA), and swept-source optical

190 In 1 patient imaged with fluorescein angiography, focal segments of retinal venul

191 iography, indocyanine green angiography, and fluorescein angiography for comparison with the patholog

192 In selected patients, Goldmann perimetry, fluorescein angiography, full-field electroretinography

193 hniques, including color fundus photography, fluorescein angiography, fundus autofluorescence (FAF),

194 imethod imaging comprised color photography, fluorescein angiography, fundus autofluorescence, and hi

195 r each patient, including color photography, fluorescein angiography, fundus autofluorescence, and op

196 Fluorescein angiography, fundus autofluorescence, and op

197 Clinical examination, fluorescein angiography, fundus photography, and spectra

198 Fluorescein angiography had the highest accuracy (97%, 3

199 Fluorescein angiography has shown potentially serious an

200 Fundus examination, fluorescein angiography, histology, and immunostaining w

201 CNV was evaluated by fluorescein angiography, histology, and quantitative con

202 on in vldlr(-/-) mice was examined by fundus fluorescein angiography, histology, double-staining of F

203 in all patients and were hyperfluorescent on fluorescein angiography, hypofluorescent on ICG angiogra

204 HARBOR analyzed color fundus photography and fluorescein angiography image data.

205 Consecutive ultra-widefield fluorescein angiography images were collected from patie

206 Ultra-widefield fluorescein angiography images were obtained in 63 eyes

207 Widefield fluorescein angiography images were reviewed for periphe

208 Fluorescein angiography imaging was performed using a To

209 d perfusion and leakage at the optic disc on fluorescein angiography immediately after AION and sever

210 NV was associated with exudative features on fluorescein angiography in 82% of cases (64/78), and on

211 Patients exhibiting neovascular signs on fluorescein angiography in either eye were excluded.

212 s was used to perform ultra-widefield fundus fluorescein angiography in infants undergoing an examina

213 e has advantages as an alternative to RetCam fluorescein angiography in infants undergoing an examina

214 g tool for performing ultra-widefield fundus fluorescein angiography in infants.

215 ocated spontaneous CNV invisible to standard fluorescein angiography in mice before retinal invasion.

216 ens, and retinal vasculature was examined by fluorescein angiography in WT and Fabry rats.

217 sensitivity of time domain OCT, relative to fluorescein angiography, in detecting new-onset neovascu

218 nificantly reduced LPC/DHA transport in vivo Fluorescein angiography indicated normal blood-retinal b

219 e were imaged with autofluorescence imaging, fluorescein angiography, indocyanine green angiography,

220 omplete ophthalmologic examination including fluorescein angiography, indocyanine green angiography,

221 d reflectance scanning laser ophthalmoscopy, fluorescein angiography, indocyanine green angiography,

222 free imaging, blue autofluorescence imaging, fluorescein angiography, indocyanine green angiography,

223 methods such as enhanced depth imaging-OCT, fluorescein angiography, indocyanine green angiography,

224 h various combinations of color photography, fluorescein angiography, indocyanine green angiography,

225 (SD OCT), fundus autofluorescence (FAF), and fluorescein angiography/indocyanine green (ICG) angiogra

226 Fluorescein angiography is an important and frequently u

227 Fluorescein angiography is important in assessing vascul

228 gonioscopy, dilated fundus examination, and fluorescein angiography is recommended in infants with s

229 Although fluorescein angiography is the criterion standard for ev

230 Intravenous fluorescein angiography (IVFA) does not show macular hyp

231 ical coherence tomography (OCT), intravenous fluorescein angiography (IVFA), indocyanine-green angiog

232 rapeutic technologies, including intravenous fluorescein angiography, laser photocoagulation, optical

233 lowing injection; both retinal thickness and fluorescein angiography leakage decreased in a dose-depe

234 Fluorescein angiography leakage was associated with a gr

235 Pretreatment ocular characteristics on fluorescein angiography (lesion type, area of neovascula

236 provider was $282.80, with 4 imaging tests (fluorescein angiography, magnetic resonance imaging, che

237 coherence tomography, presence of leakage on fluorescein angiography, mean change in lesion size, and

238 Among 467 eyes with fluorescein angiography, mean total lesion area was 12.9

239 erwent indocyanine green angiography, fundus fluorescein angiography, mesopic microperimetry, and mul

240 digital color imaging, red-free photography, fluorescein angiography, near-infrared reflectance, and

241 l color imaging, spectral-domain OCT images, fluorescein angiography, OCT angiography images, and en

242 tral-domain optical coherence tomography and fluorescein angiography of inner foveal structural abnor

243 thalmic examinations included visual acuity, fluorescein angiography, optical coherence tomography, a

244 as identified on dilated fundus examination, fluorescein angiography, or both in 11 eyes of 6 patient

245 nce of cataract (P = .05), foveal leakage on fluorescein angiography (P = .04), and increased central

246 Intravenous fluorescein angiography performed in 1 eye depicted the

247 Ultra-widefield fluorescein angiography provides an insight into the rel

248 ace between two domains (i.e. funduscopy and fluorescein angiography) provides an unrivaled way for t

249 andard 7-field stereo fundus photography and fluorescein angiography, respectively.

250 us autofluorescence results, ultra-widefield fluorescein angiography results, and indocyanine green a

251 Fluorescein angiography revealed active leakage, especia

252 Fluorescein angiography revealed delayed retinal arteria

253 Fluorescein angiography revealed early hyperfluorescence

254 Fluorescein angiography revealed early hypofluorescence

255 e large choroidal vessels and optic atrophy; fluorescein angiography revealed gradual restoration of

256 Fluorescein angiography revealed no choroidal neovascula

257 Fluorescein angiography revealed progressive neovascular

258 the anterior chamber (P = .007); the highest fluorescein angiography score (P = .011); age (P < 0.001

259 bvious on FA than on SD OCT, suggesting that fluorescein angiography should be performed when new-ons

260 Fluorescein angiography showed a late hyperfluorescence

261 Fluorescein angiography showed bilateral dilated, ectati

262 Fluorescein angiography showed filling defects in retina

263 Fluorescein angiography showed no definite leakage in an

264 Fluorescein angiography showed saccular lesions that fil

265 ts (n = 6 eyes of 3 patients) with widefield fluorescein angiography showed several retinal vascular

266 Fluorescein angiography showed staining during the late

267 Fluorescein angiography, spectral domain optical coheren

268 graphy, fundus autofluorescence, intravenous fluorescein angiography, spectral-domain OCT and OCT ang

269 previous time points and anatomic results on fluorescein angiography, spectral-domain ocular coherenc

270 ging findings, including fundus photography, fluorescein angiography, spectral-domain optical coheren

271 olor photographs, near-infrared reflectance, fluorescein angiography, spectral-domain optical coheren

272 ation and proliferation were monitored using fluorescein angiography, spectral-domain optical coheren

273 gathering included fundus color photographs, fluorescein angiography, spectral-domain optical coheren

274 prospective AMD DOC Study demonstrated that fluorescein angiography still remains the best method to

275 Serious complications can occur with fluorescein angiography, such as an anaphylactic reactio

276 ion when choosing the healthcare setting for fluorescein angiography, such as the immediate availabil

277 Fluorescein angiography suggests that vascular perfusion

278 uate retinal capillary blood flow instead of fluorescein angiography, the reflectance pattern of bloo

279 esting including OCT, electrophysiology, and fluorescein angiography to differentiate optic nerve fro

280 eld fundus imaging including pseudocolor and fluorescein angiography using an Optos 200Tx device.

281 erwent intraoperative ultra-widefield fundus fluorescein angiography using the modified Heidelberg Sp

282 s with DR that had undergone ultra-widefield fluorescein angiography (UWFA) with associated color pho

283 inical study to determine if ultra-widefield fluorescein angiography (UWFA), spectral-domain optical

284 Ultra-wide-field fluorescein angiography (UWFA), which captures up to 200

285 Ultra-widefield fluorescein angiography (UWFA; California Optos [Optos,

286 wed for abnormal findings on ultra-widefield fluorescein angiography (UWFFA) and OCT.

287 sion that co-localized with the CNVM seen on fluorescein angiography was detected in all eyes by Fd-O

288 Follow-up fluorescein angiography was done on other animals until

289 Fluorescein angiography was not found to be associated d

290 Fluorescein angiography was performed in 17 of 43 diabet

291 of peripheral avascular areas on intravenous fluorescein angiography was possible in 2 probands with

292 Ultra-widefield fundus fluorescein angiography was successfully performed in al

293 autofluorescence, and indocyanine green and fluorescein angiography, was available in most cases.

294 ence tomography (SD-OCT) and nonperfusion on fluorescein angiography, we observed that retinal capill

295 Optical coherence tomography (OCT) and fluorescein angiography were also obtained at some visit

296 l-domain OCT, near-infrared reflectance, and fluorescein angiography were investigated.

297 with type of choroidal neovascularization on fluorescein angiography were not confirmed.

298 phy, optical coherence tomography and fundus fluorescein angiography were performed where indicated.

299 sualized completely around the nerve head by fluorescein angiography, whereas the network was readily

300 ing techniques, including widefield imaging, fluorescein angiography (with peripheral sweeps), and OC